Attorney Advertising · Informational Only · Not Legal Advice · Editorial Policy

doTerra Essential Oils Pyramid Scheme Class Action

DoTERRA International has not been officially designated as an illegal pyramid scheme by federal authorities, but the company has faced significant legal challenges related to deceptive marketing practices and labor law violations. In March 2023, the Federal Trade Commission took enforcement action against three individual doTERRA distributors for making false COVID-19 health claims without FDA approval, resulting in $15,000 penalties each. Additionally, a collective action lawsuit filed in 2023 alleges that doTERRA failed to properly calculate overtime pay for hourly employees—a systemic issue the company’s own management discovered and acknowledged.

These enforcement actions and lawsuits highlight serious compliance problems within doTERRA’s distributor network and internal operations, even if the company itself has not been shut down as a pyramid scheme. The distinction matters: while doTERRA operates as a multi-level marketing (MLM) company with a compensation structure that has pyramid scheme characteristics, it has not been legally determined to be an illegal pyramid scheme by the FTC or federal courts. However, the company’s enforcement history and the nature of its business model—which emphasizes recruitment and personal consumption requirements for distributors—raise legitimate concerns about whether participants generate income primarily from product sales to genuine retail customers or from recruiting other distributors.

Table of Contents

In March 2023, the Federal Trade Commission announced enforcement action against three doTERRA distributors: Eliza Johnson Bacot (a nurse practitioner), Lauren Busch (a former registered nurse), and Dr. Tina Wong (a pediatrician). These distributors were each fined $15,000 for making unsubstantiated COVID-19 health claims during webinars in early 2022. The claims were particularly problematic because they came from healthcare professionals with credentials that lent false authority to the statements.

Specifically, the distributors claimed that doTERRA essential oils could prevent, treat, or cure COVID-19, with detailed assertions about specific products—including claims that tangerine oil and cilantro oil could help “detox” and repair damage from COVID-19 infection. Under the FTC Act and the COVID-19 Consumer Protection Act, making health claims about products without FDA approval is illegal, especially during a public health emergency when misinformation can cause direct harm. The FTC issued permanent injunctions against all three distributors, prohibiting them from making any health claims about doTERRA products or any other products unless they have competent and reliable scientific evidence. This action reveals a pattern: while doTERRA as a corporate entity did not pay the fines, its distributor network was operating without proper compliance controls, allowing health professionals to spread dangerous medical misinformation through company-affiliated channels.

What Legal Actions Has doTERRA Faced Related to False Health Claims?

The Overtime Pay Lawsuit and What It Reveals About DoTERRA’s Employment Practices

A more structural problem emerged in October 2023 when a collective action lawsuit was filed against doTERRA International in the U.S. District Court for the District of Utah (Bingham v. doTerra International LLC, Case No. 2:23-cv-00707).

The lawsuit alleges that doTERRA failed to pay hourly employees overtime compensation at the required 1.5x rate when calculating their earnings. What makes this violation particularly significant is that doTERRA’s own management discovered the error in January 2023 and acknowledged it internally: the company’s payroll system “had been undercalculating overtime pay because the Upsell bonus and other non-discretionary bonuses were not included in the overtime rate calculation.” This is not a case of a technical accounting dispute—it is evidence that doTERRA’s payroll system was systematically underpaying employees for years without their knowledge. The collective action has been conditionally approved and targets current and former hourly employees. The company’s failure to correct this error immediately upon discovery, and instead apparently allowing the case to proceed to litigation, suggests either a lack of internal compliance infrastructure or a deliberate decision to contest the claims despite knowing about the problem. For employees who worked overtime during this period, the financial impact compounds over years of underpayment.

Legal Actions Against DoTERRA and Its Distributors (2023)FTC Health Claims Penalty (Per Distributor)15000$, count, count, countNumber of Distributors Fined3$, count, count, countOvertime Pay Underpayment Lawsuit (Status)1$, count, count, countPermanent Injunction (Health Claims)3$, count, count, countSource: Federal Trade Commission (March 2023), U.S. District Court for District of Utah

How Does DoTERRA’s Business Model Compare to Other Multi-Level Marketing Companies?

DoTERRA operates as a multi-level marketing company, which means it generates revenue from both product sales and the recruitment of new distributors into a hierarchical structure. The risk with MLM models is that they can function as pyramid schemes if the primary source of revenue comes from recruitment rather than genuine retail sales to outside customers. In doTERRA’s case, distributors are required to purchase products for personal consumption and to maintain an “active” status, which creates an incentive structure where recruitment may be more profitable than selling to actual customers.

Compare this to companies that sell products primarily through retail channels without requiring sales representatives to purchase inventory. With those models, distributors earn commissions on genuine customer sales. In MLM structures like doTERRA’s, distributors often make more money from recruiting downlines than from selling products, and the company benefits because it sells more product to the new recruits themselves. This creates a situation where the business model itself encourages misleading income claims (like the ones the FTC addressed) because distributors are motivated to recruit others into a system that will likely not generate significant retail income for most participants.

How Does DoTERRA's Business Model Compare to Other Multi-Level Marketing Companies?

What Should Potential DoTERRA Participants Know Before Joining?

Before joining doTERRA as a distributor, you should understand that the company’s compensation structure does not guarantee income, and research shows that the vast majority of MLM participants make little to no profit. The FTC’s actions against doTERRA distributors demonstrate that the company’s compliance training is insufficient to prevent health claim violations, which means you could face legal liability if you make claims about essential oils treating or preventing disease. The overtime lawsuit reveals that even doTERRA’s own employees have not been treated fairly under employment law, which raises questions about the company’s overall commitment to legal compliance.

You should also know that the initial startup costs for becoming a doTERRA distributor can range from several hundred to several thousand dollars, depending on the starter kit you choose. While the company claims these are optional, higher-tier kits are often promoted as generating greater income potential. Additionally, doTERRA’s product pricing is significantly higher than comparable essential oil products sold through retail channels, which means you would be selling to customers in a competitive market where price is a major factor. Before committing money or time to doTERRA, review income disclosures from MLM companies (both doTERRA and similar companies) to understand realistic earning expectations.

What Are the Red Flags in DoTERRA’s Marketing Claims and Distributor Recruitment?

The three distributors penalized by the FTC in 2023 were using language that had been warned against repeatedly in FTC guidance about health claims. The fact that healthcare professionals with medical credentials were still making these claims suggests that doTERRA’s training and compliance monitoring are inadequate. Red flags to watch for include any claim that essential oils can treat, prevent, or cure any disease; income claims that suggest you can earn substantial money quickly; pressure to purchase large inventory or premium starter kits; and recruitment-focused compensation structures where most of your income would come from recruiting others rather than customer sales.

Another warning sign is the use of social media and personal networks to recruit, combined with emotional language about lifestyle changes and personal transformation. When these marketing elements are present alongside health claims (even indirect ones), you are likely being recruited into a system optimized for the company’s profit, not your financial success. The FTC’s enforcement action specifically targeted webinars, which are a common recruiting tool for MLMs because they allow for high-pressure sales presentations to groups of potential recruits in an informal setting.

What Are the Red Flags in DoTERRA's Marketing Claims and Distributor Recruitment?

What Happened With The FTC Settlement and Permanent Injunctions?

The three distributors who were fined by the FTC in March 2023—Bacot, Busch, and Wong—are now subject to permanent injunctions that prohibit them from making unsubstantiated health claims about any products. This is a critical detail: the injunction is not limited to doTERRA products, but applies to any product they might promote in the future. Violating a permanent injunction can result in civil penalties of up to $45,787 per violation, which means these distributors face severe financial consequences if they make similar claims again.

The FTC’s action also serves as a warning to other doTERRA distributors and to the company itself about the seriousness of health claim violations during a public health emergency. However, the fact that the FTC took action against individual distributors rather than the company suggests that doTERRA might successfully argue it is not directly responsible for policing the millions of small claims made by independent distributors online and in social media. This creates a compliance gap: distributors face legal liability, but the company’s corporate accountability is limited unless the FTC can demonstrate that doTERRA directed, encouraged, or knew about specific illegal claims.

DoTERRA’s track record—with the FTC taking action against distributors for health claims in 2023 and the company’s own admission that it was systematically undercalculating overtime pay—suggests ongoing structural compliance problems. The company has not announced major changes to its distributor training or its internal compliance monitoring to address these issues, which means the same problems could recur.

Future potential class actions or regulatory actions could involve income claim violations, inadequate disclosure of earning potential, or additional health claim enforcement if the company does not fundamentally change how it trains and monitors its distributor network. For consumers and potential participants, this history means you should be extremely cautious about income promises and especially about any health-related claims made by doTERRA distributors. The overtime lawsuit also raises questions about whether doTERRA will comply voluntarily with labor law or if additional legal action will be necessary to secure fair compensation for current and former employees.

Sources

You Might Also Like

Open Settlements You Can Claim Now

Browse current class action settlements accepting claims — several require no proof of purchase:

We use cookies to run this site, measure how it’s used, and show ads. Choose “Essentials only” to limit cookies to what the site needs to work. Privacy Policy.